Charles Quesenberry to Sensitivity and Specificity
This is a "connection" page, showing publications Charles Quesenberry has written about Sensitivity and Specificity.
Connection Strength
0.156
-
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med. 2016 Apr 05; 164(7):456-63.
Score: 0.031
-
Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs). J Am Acad Dermatol. 2015 Sep; 73(3):444-50.
Score: 0.030
-
Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):739-46.
Score: 0.029
-
Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. J Clin Oncol. 2010 Oct 01; 28(28):4300-6.
Score: 0.021
-
Pharmaceuticals that cause mammary gland tumors in animals: findings in women. Breast Cancer Res Treat. 2009 Jul; 116(1):187-94.
Score: 0.019
-
The cost of health conditions in a health maintenance organization. Med Care Res Rev. 2000 Mar; 57(1):92-109.
Score: 0.010
-
Computer-based models to identify high-risk adults with asthma: is the glass half empty of half full? J Asthma. 1999 Jun; 36(4):359-70.
Score: 0.010
-
Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med. 1993 Jan 01; 118(1):1-6.
Score: 0.006